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Abstract
Components of the mitochondrial branched chain K-ketoacid dehydrogenase multienzyme complex are all encoded by
nuclear genes. The functional complex is formed with a known stoichiometric relationship of subunits, but how they enter the
mitochondria and form the complex is not defined. Although cytosolic precursors for several of the proteins have been
identified, the requirements for import and processing have not been described. Here we demonstrate the similar
requirements for in vitro import and processing of the three catalytic subunits unique the this complex. Import was not
affected by the amount of endogenous BCKD within the mitochondria. No cooperativity or competition among the subunits
for import was found when subunits were used in combination. The relative rates of entry are E1KsE2vE1L, making E1L
the limiting component supporting previously reported observations. 0167-4889 / 98 / $ ^ see front matter ß 1998 Elsevier
Science B.V. All rights reserved.
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1. Introduction
Mitochondria provide a multitude of functions for
a cell, many of which depend on the activity of mul-
tienzyme complexes. With the exception of com-
plexes in the electron transport chain that use com-
ponents encoded by both the mitochondrial and
nuclear genomes, all other mitochondrial multien-
zyme complexes are encoded entirely by nuclear
genes [1,2]. Without a focal point for complex assem-
bly as provided by the proteins synthesized within a
mitochondrion, it is unclear what properties of nu-
clear encoded proteins are used for assembly of these
complexes. Nuclear encoded mitochondrial matrix
proteins require mitochondria targeting sequences
(MTS) at their amino terminal ends for import and
localization [3,4]. These proteins are believed to re-
main unfolded for transport across the mitochondrial
membranes and the MTS may aid in keeping them in
this form [5,6]. Some preproteins use chaperone pro-
teins in the cytosol to maintain them in an unfolded
state for import. Additional chaperone proteins with-
in the mitochondrial matrix aid in import and fold-
ing of the processed proteins [7,8]. However, the
process of assembly of the mature proteins into func-
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tional complexes and the role of chaperones in this
process is just beginning to be examined [9,10].
In order for a multienzyme complex to assemble,
all components of the complex must be present with-
in the mitochondrion and presumably in juxtaposi-
tion. This process of assembly must begin with im-
port of the component subunits. Here we de¢ne the
mitochondrial import requirements for human
branched chain K-ketoacid dehydrogenase (BCKD)
(EC 1.2.4.4) as a model for a nuclear encoded multi-
enzyme complex. We previously showed that one
component of the complex is limiting and overex-
pression of this subunit increased the total amount
of BCKD within the mitochondria [11]. Here we
asked whether the import of that same subunit or
any of the BCKD subunits is limiting.
BCKD catalyzes the oxidative decarboxylation of
the branched chain K-ketoacids (BCKA) derived by
transamination of leucine, isoleucine and valine [12].
All four proteins that form the catalytic core are
encoded in the nucleus and all have been cloned
[13^16]. The decarboxylase (E1) removes CO2 from
the BCKA and structurally is comprised of an K2L2
hetero-tetramer. This interaction of the two proteins
is necessary for stabilization of each against degra-
dation [17]. Twelve E1 subunits decorate 24 mono-
mers of the acyltransferase (E2) which forms the core
of the complex. E2 transfers the residual branched
chain acyl group to coenzyme A reducing a cova-
lently bound E2-lipoate in the process. Reoxidation
of the lipoate uses dihydrolipoamide dehydrogenase
(E3), a £avoprotein also used by other mitochondrial
ketoacid dehydrogenase complexes [12]. Six of the E3
homodimers also reside on the surface of the E2 core
[18]. Naturally occurring human mutations in the
genes for these components result in a condition
known as maple syrup urine disease (MSUD) [19].
Amino acid substitutions in these proteins as a result
of these mutations provide powerful tools for evalu-
ation of subunit import and BCKD assembly.
At this point little is known about the import and
processing of the BCKD proteins by the mitochon-
dria. A role for chaperone proteins in this process
has been implicated from studies of expression of
the mature BCKD subunits in Escherichia coli
[20,21]. Precursor forms of E1K and E2 were identi-
¢ed by immunological techniques in whole cell ex-
tracts, but the precursor form of E1L was not de-
tected [22]. Conditions for import and processing
were not de¢ned in the Clarkson study. In vitro im-
port and processing of the E2 component was dem-
onstrated as part of the initial characterization of the
¢rst cDNA clone [23]. In that report the dependence
on a membrane potential and proteolytic processing
within the mitochondrial matrix was described. Here
we present a detailed characterization for in vitro
import and processing of all three components. Im-
port of E1L appears to be the limiting component, at
least for E1 formation. E1L is the same subunit
shown previously to be limiting in BCKD formation
[11,24,25].
2. Materials and methods
2.1. Plasmid construction
cDNA encoding the full preproteins for the
BCKD-speci¢c subunits [14^16] were placed in
pGEM7zf+ (Promega, Madison, WI) so that the
T7 promoter drives transcription. cDNAs encoding
only the mature portions of the BCKD-subunits
were engineered to include an initiating AUG and
placed in pET 11d vectors (Novagen, Madison,
WI). Transcripts are produced from the T7 pro-
moter.
2.2. In vitro protein synthesis
Proteins were prepared from the described plas-
mids using Promega TNT coupled transcription/
translation system according to the manufacturer’s
directions using T7 polymerase. Proteins were radio-
labeled with [35S]methionine or [35S]cysteine in the
case of E1L (10 mCi/ml) (Amersham, Arlington
Heights, IL). Labeled products were detected by
autoradiography using Hyper¢lm (Amersham) or
by exposure to a phosphorimaging screen (Molecular
Dynamics, Sunnydale, CA).
2.3. Immunoblotting
Unlabeled proteins made with the TNT system
were detected by the following adaptation of the
Western blot protocols of He¡el¢nger et al. [26]
and detected with an ECL kit (Amersham). The pro-
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tein-containing nitrocellulose was soaked in IM2 (50
mM Tris-HCl pH 7.4, 150 mM NaCl, 5 mM EDTA,
0.25% gelatin, 1% Tween 20) overnight after two
rinses in IM2 and then washed (4 ml/cm2) in IM2
for 5 min before incubation with polyclonal anti-
BCKD rabbit serum (15 Wl in 15 ml IM2) using 1.5
ml/cm2. Unbound primary antiserum was removed
with two rinses, a 15 min soak and two 5 min soaks
in IM2. Goat anti-rabbit horseradish peroxidase
(Bio-Rad, Hercules, CA) (2 Wl in 50 ml IM2) was
allowed to bind for 30 min followed by washes as
above. Visualization utilized the ECL-Protein Detec-
tion kit (Amersham) with Hyper¢lm MP.
2.4. Import and processing of preproteins by
mitochondria
Mitochondria were prepared by the method of
Greenawalt [27] either from the liver of a mouse
starved overnight or from DG75 human lympho-
blasts maintained in culture [23]. Mitochondrial pro-
tein concentration was estimated by coomassie dye
binding using Bio-Rad reagents and mitochondria
were diluted to a ¢nal concentration between 10
and 15 mg protein/ml for use in import reactions.
Individual in vitro prepared preproteins were
tested for import by incubation of equal volumes
of translation mix and mitochondria for indicated
times at 30‡C. Trypsin digestion to remove the outer
mitochondrial membranes and bound preprotein was
with 0.1 volume of 1.25 mg trypsin/ml (Sigma, St.
Louis, MO) for 10 min on ice. Digestion was stopped
by the addition of 0.1 volume of soybean trypsin
inhibitor (2.5 mg/ml) (Sigma) [23]. When two in vitro
prepared preproteins were included in the import re-
action, only one was made with radiolabel. To assure
that the unlabeled preprotein had been synthesized,
the protein in the lysate was detected by immuno-
blotting.
The mitochondrial membrane potential was dis-
rupted by incubation with rhodamine 123 (60 Wg/ml)
for 10 min prior to addition of preprotein to
the reaction mixture [23]. ATP was depleted from
the lysate and mitochondria by treatment with 0.02
units apyrase (Sigma), 8 WM antimycin A, 20 WM
oligomycin, 8 mM potassium ascorbate and 0.2
mM N,N,NP,NP-tetramethylphenylenediamine (Sig-
ma) as described [28]. ATP concentration was rees-
tablished by addition of 5 Wl of 440 mM ATP (Boeh-
ringer-Mannheim, Indianapolis, IN), adjusted to pH
7.4 with KOH, at the beginning of import and again
halfway through the incubation period.
Determination of internal or external ATP require-
ments was made by treating the mitochondria with
carboxyatractyloside (Sigma) (25 Wg/ml) to block the
adenine nucleotide translocator under the conditions
described above. ATP was restored to the matrix by
addition of K-ketoglutarate to 5 mM for 3 min prior
to addition of radiolabeled preprotein [29]. ATP was
restored to the outside of the mitochondria by addi-
tion of an ATP generating reaction that included 7.5
mM creatine phosphate (Sigma) and 1.5 mg creatine
phosphokinase (Sigma) [29].
Quanti¢cation of 35S-labeled proteins was per-
formed on a Molecular Dynamics Phosphorimager
and densitometry done with a Molecular Dynamics
Personal Densitometer. Data were analyzed using
ImageQuantNT software. Percent imported was cal-
culated as the fraction of the mature protein inside
the mitochondria protected from trypsin digest div-
ided by the total labeled preprotein present in the
reaction mixture at the beginning of import.
2.5. Animal care
All mice were cared for and treated according to
the AMVA guidelines, the Guide for the Care and
Use of Laboratory Animals and the Animal Welfare
Act under the supervision of the Emory University
IACUC.
3. Results
Preproteins for E1K, E1L, and E2 were prepared
as described in Section 2. Since E1L has only four
methionine residues and one is lost with cleavage of
the MTS, this protein was labeled with [35S]cysteine
instead of [35S]methionine as with the other proteins.
Mitochondria isolated from either mouse liver or
DG75 cultured human lymphoblasts were used for
the import studies. Both cell types have endogenous
BCKD within their mitochondria. Nearly identical
patterns for in vitro import and processing were
found regardless of the origin of the mitochondria
although the liver mitochondria accumulated a high-
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er percentage of the imported protein (Fig. 1). Only
the single radiolabeled preprotein was present in
these studies. Rates of entry did vary among the
three subunits being at least three times faster for
E1K than for either of the other two. The slow im-
port rate for E1L may contribute to the regulation of
the amount of BCKD complex formed in mitochon-
dria or at least the E1 component, supporting an
earlier conclusion that E1L concentration in£uences
complex formation [11].
Requirements for import and processing of these
precursor proteins is illustrated in Figs. 2 and 3 for
the liver mitochondria. All parameters tested with
mitochondria from DG75 cells provided identical re-
sults (data not shown). The data revealed no unusual
properties for import by any of the BCKD compo-
nents from those de¢ned for other nuclear encoded
matrix proteins [8]. Results from at least three inde-
pendent preparations of mitochondria support the
need for ATP only on the matrix side for all three
subunits. When proteins lacking the MTS were made
in vitro, no import occurred. These proteins adhered
Fig. 1. Rate determination for import of BCKD preproteins
into mitochondria at 30‡C. Percent import was determined by
the ratio of mature radiolabeled protein within the mitochon-
dria and protected from proteolysis to radiolabeled preprotein
presented to the mitochondria in the import reaction mixture.
Panel A depicts import into mouse liver mitochondria. Two
subunits were imported with each preparation of mitochondria
in various combinations. Each subunit was tested at least three
times. A typical import pattern is depicted for each subunit.
Panel B depicts import into mitochondria from DG75 cells.
Only one subunit was tested with each preparation of mito-
chondria due to limiting amounts of the organelles from these
cultured cells. Error bars represent the average þ S.D. of at least
three separate determinations.
Fig. 2. Import of preproteins for the BCKD complex in mouse
liver mitochondria. Additions to the reaction mixture are indi-
cated at the top. Lane 1: in vitro translation product; lane 2:
translation product incubated with mouse liver mitochondria
(15 Wg protein/reaction) for 40 min at 30‡C; lane 3: as lane 2
but treated with trypsin and the end of the incubation period;
lane 4: as lane 2 but mitochondria treated with rhodamine 123;
lane 5: as lane 4 but treated with trypsin. Details of conditions
are described in Section 2.
Fig. 3. Dependence of BCKD subunit preprotein import on
ATP. Conditions for samples in each lane are given at the top.
Details of conditions are provided in Section 2.
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to the mitochondria but the bound protein was sen-
sitive to trypsin, consistent with their not being im-
ported (data not shown).
The amino acids of the MTS for E1K and E1L
show sequence similarity, an unusual ¢nding for nu-
clear encoded mitochondrial proteins [15]. Despite
the similarity, the two subunits have markedly di¡er-
ent import rates (Fig. 1). Other investigators have
shown that the amino acid sequence of an MTS
and the mature portion of some proteins will deter-
mine the import properties [30,31]. Still the similarity
in MTS sequence was intriguing and raised the pos-
sibility that these two preproteins would compete or
cooperate with each during import. To eliminate the
complication of unequal 35S labeling of the two pro-
teins, only one was made with radiolabel. Production
of unlabeled protein was con¢rmed by Western blot
analysis. Each protein was made with or without
radiolabel and used in both combinations to elimi-
nate an isotope e¡ect. The results were identical in all
combinations and even when the unlabeled protein
was present at 100-fold excess there was no observed
e¡ect on the import of the labeled protein (data not
shown).
Despite the similarity in MTS amino acid se-
quence, E1K was imported at least three times faster
than E1L. The MTS was analyzed by computer using
the GCG program. Placing the ¢rst 18 amino acids
of the MTS on an helical wheel, the two arginine
residues in this region for E1L align 180‡ apart.
The three arginines present in the ¢rst 18 residues
of the MTS for E1K cluster on one side (Fig. 4)
[32,33]. All other properties tested were similar for
the two amino acid sequences. To test the impor-
tance of the MTS for import, the nucleotide sequence
encoding the MTS for each subunit was exchanged.
Fig. 4. Display of the ¢rst 18 residues of the mitochondrial tar-
geting sequence for BCKD E1K and E1L arranged around a
helical wheel.
Fig. 5. E¡ect of using the E1KMTS to direct the import of the
mature E1L protein into mouse liver mitochondria (15 Wg pro-
tein/reaction) at 30‡C. Further details are given in the text.
Fig. 6. Rate of pre-E1L import comparing two proteins with
single amino acid substitutions with wild-type protein. Circles
represent E1LN126Y, squares represent E1LQ212P, and dia-
monds the wild-type E1L. Conditions are as in Fig. 1.
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When import of E1L was driven by the MTS for
E1K, E1L was imported at a faster rate than the
native preprotein but not equal to the rate for pre-
E1K (Fig. 5). However, when the nucleotide sequence
encoding the MTS for E1L was placed in front of the
nucleotides encoding the mature portion of E1K, a
truncated protein was found that was not imported
into the mitochondria and remained trypsin sensitive.
This behavior was reminiscent of the observations
made with the mature proteins when they were tested
for import. In an attempt to overcome this result the
nucleotide sequence around the ¢rst AUG was
changed to conform to a Kozak consensus for op-
tional ribosome binding [34]. Neither this nucleotide
change, nor the use of higher temperature during the
translation phase of the reaction to melt secondary
structure of the mRNA, produced a full-length pre-
protein.
Results shown in Fig. 5 indicate that amino acids
in the mature portion of E1L in£uence the import
properties. Amino acid substitutions within the ma-
ture sequence of E1L can result in dysfunction of the
protein and reduced abundance [35]. Two single ami-
no acid substitutions in E1L were tested for their
e¡ect on import. The E1LN126Y protein was shown
to be causative of MSUD with reduced amounts of
this altered protein found in the mitochondria of
patient derived cells and those from the contributing
parent[35]. An E1LQ212P protein was created
through PCR ampli¢cation error but was not tested
for e¡ect on BCKD activity or abundance. As yet
E1LQ212P has not been found in either the normal
or MSUD patient population. Comparing these two
proteins to import of wild-type E1L showed no dif-
ference on import function (Fig. 6).
4. Discussion
In vitro prepared preproteins for the E1K, E1L,
and E2 components of human BCKD have similar
energy and cofactor requirements for import into
mitochondria. The pattern of import, E1KsE2
vE1L, among the three proteins was independent
of the source of mitochondria. The rate and extent
of import for all subunits was higher for liver, which
we had shown previously to contain a two-fold lower
concentration of BCKD per mitochondrion than
DG75 cells [11]. Volman has reported that hepatoma
cells have fewer mitochondria than hepatocytes but
the organelles from each cell type appear the same
[36]. Thus we assume the BCKD concentration per
mitochondria in the hepatocytes to be equal to or
less than that found for the HepG2 cells [11].
Whether these same properties of import also oc-
cur in vivo remains to be shown. Clarkson and Lind-
say were able to demonstrate preprotein for E2 and
E1K in whole cell extracts when cells were poisoned
for mitochondrial function[22]. However, the pre-
E1L was not detected, and it now seems likely this
was due to their use of [35S]methionine in protein
labeling. The low methionine content of E1L makes
detection di⁄cult or impossible under conditions
normally used in experiments of this type. Using
[35S]cysteine we overcame the labeling di⁄culty and
the in vitro design allowed analysis of the individual
subunits. It is not known whether the slow rate of
import for E1L also in£uenced their results although
translation of E1L was not a problem in our studies.
Under normal conditions of cell culture or animal
tissue preparation, we have not been able to identify
the presence of preprotein for any subunit of the
BCKD using antibody detection. This suggests that
e⁄ciency of import in vivo is high or that any pre-
cursor in the cytosol not imported is rapidly de-
graded.
The ATP requirement determined in our studies
appears to be associated with the functions within
the matrix [33]. Removal of ATP from the medium
and mitochondria prevented import for all subunits.
Import was restored only when matrix ATP concen-
trations were reestablished. Under the conditions
used here (Fig. 3, lane 7), some preprotein is pro-
tected from trypsin digestion suggesting that process-
ing is limiting with a low ATP concentration. Addi-
tion of ATP only to the medium did not restore
import capability for these proteins, supporting the
idea that the MTS on these preproteins helps to keep
the proteins unfolded in the cytosol [5,6]. These ¢nd-
ing comply with a previous report that the need for
external ATP is precursor protein speci¢c while ma-
trix ATP is required by all imported proteins [29].
Computer assisted analysis of the MTS for each
subunit shows a typical alpha helix for all three pre-
proteins. By the programs used, the predicted length
of the alpha helix region at the amino terminal end
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for each MTS varies but there appear to be no dis-
tinguishing features for one from another. Amino
acid sequence for the E1K and E1L MTS is similar
throughout the entire region, an unusual ¢nding
among any mitochondrial preproteins studied thus
far [15,37]. However, in the ¢rst 18 residues forming
the ¢rst complete helix, two arginines align 180‡
apart for E1L while three arginine molecules align
on one side of the helix in E1K. This charge distri-
bution may account for the signi¢cant rate of import
di¡erence observed for the two subunits. Indeed, us-
ing the MTS for E1K to direct import of mature E1L
did improve the rate of entry and processing but not
to that seen for the native pre-E1K. Studies by our-
selves and others have demonstrated that the amount
of E1L within the mitochondria can determine the
total amount of BCKD present, the slow import of
E1L would help to limit the amount of this subunit
within the mitochondria and therefore the concentra-
tion of E1L within the organelle [11,24,25].
The length of the MTS for E1K, E1L, and E2 is 46,
50, and 62 amino acids respectively. From our data
the subunit with the fewest residues in the MTS
(E1K) is imported at the fastest rate and accumulates
to a higher concentration. A recent report suggested
that a longer MTS enhanced entry rate [38]. These
authors reasoned the longer MTS helped unfold the
protein since the MTS could span both membranes
of the mitochondria. They truncated a single MTS
from 95 residues down to 35 residues and used these
to import DHFR, a protein not normally found in
the mitochondria. Our data suggests that the length
of the MTS may not be as important as the combi-
nation of MTS and mature protein sequence in the
passage. We used the same method to report percent
import as these authors so the method of analysis
cannot be given as the reason for the di¡erence.
The observation that using the E1K-MTS to direct
import of mature E1L improved the entry rate and
amount of E1L imported also works against the idea
that length of the MTS is paramount for import.
Unfortunately, the reverse exchange of E1L-MTS
to direct mature E1K import could not be tested.
Under various reaction conditions the in vitro pro-
duced protein had an Mr value of about 38 000. This
protein is not imported into mitochondria suggesting
that it did not contain an MTS. Examination of the
deduced amino acid sequence revealed methionine
residues at positions 37, 64, 70 and 87 of the mature
protein. If translation begins with residue 64 or 70 it
would produce a protein with the mobility observed
for this in vitro made product. The Kozak consensus
sequence (GCC A/GCC AUG G) for ribosome bind-
ing is best met by the nucleotide sequence around
M70 (AAC ACC AUG G) rather than M64 (AAG
AGC AUG A) supporting the idea that this AUG
serves as the start of translation. Although the E1L-
MTS coding sequence does not conform to the Ko-
zak consensus (GCG GGG ATG G), it obviously
works well for synthesis of the native E1L preprotein.
However, when the encoding nucleotide sequence
was placed in front of the coding sequence for ma-
ture E1K, the engineered RNA apparently assumes a
conformation that makes the initiating AUG inacces-
sible to the ribosome. Modifying the sequence to
conform with the Kozak consensus or using elevated
temperatures for translation did not alter the pattern
of translation. The exact nature of this mRNA con-
¢guration remains to be determined.
The similarity in amino acid sequence for the MTS
on E1K and E1L raised the possibility that coordina-
tion of import exists for these two subunits. Forma-
tion of the K2L2 tetramer has been shown to stabilize
each protein against turnover and therefore coordi-
nating the import of these two subunits would help
to maintain the necessary ratio for E1 formation [17].
However, no obvious competition, nor cooperativity
between the two subunits for the import process was
found under the in vitro conditions. The possibility
still exists that under in vivo conditions, cooperativ-
ity does occur.
Amino acid substitutions in E1L have been shown
to result in decreased activity of BCKD and a phe-
notype of maple syrup urine disease [35]. An
E1LN126Y substitution was also shown to result in
reduced levels of this protein within the mitochon-
dria of cells from the proband and the contributing
parent. Since the amino acid sequence of E1L can
in£uence import (Fig. 5), we asked whether the
E1LN126Y protein had reduced import rates. For
comparison we used the wild-type sequence and an-
other amino acid substitution that was a PCR gen-
erated substitution E1LQ212P not characterized for
activity or abundance. No di¡erence in import or
processing properties were observed for the three
proteins. Thus, either protein instability must be in-
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voked as the reason for the observed decreased con-
centration within the mitochondria or the import in
vivo utilizes additional factors which could be in£u-
enced by the amino acid substitution and thus slow
transport. Other amino acid substitutions may be
found with far more dramatic e¡ect on import, espe-
cially those within the MTS but these remain to be
uncovered or tested by design.
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